Mast cell-specific CysLT2 receptor signaling inhibits cysteinyl leukotriene-dependent mast cell activation and type 2 allergic lung inflammation
Cell Reports · 2026-01 · 45 (1) · 116758
DOI: 10.1016/j.celrep.2025.116758 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2026-01. Verfasst von Jun Nagai und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Harvard Medical School, Boston, MA, USA; Jeff and Penny Vinik Center for Allergic Disease Research, Division of Allergy and C…. Hauptthemen laut MEDLINE: Receptors, Leukotriene, Mast Cells, Signal Transduction, Cysteine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NIAID NIH HHS, NIDCD NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Harvard Medical School, Boston, MA, USA; Jeff and Penny Vinik Center for Allergic Disease Research, Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, MA, USA. Ele…
- Jeff and Penny Vinik Center for Allergic Disease Research, Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, MA, USA.
- Department of Medicine, Harvard Medical School, Boston, MA, USA; Jeff and Penny Vinik Center for Allergic Disease Research, Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, MA, USA.
- Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi 980-8578, Japan; Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501, Japan.
- Department of Medicine, Harvard Medical School, Boston, MA, USA; Department of Pediatrics, Harvard Medical School, Boston, MA, USA; Jeff and Penny Vinik Center for Allergic Disease Research, Division of Allergy and Clin…
Förderung
- NHLBI NIH HHS
- NIAID NIH HHS
- NIDCD NIH HHS
- Japan Agency for Medical Research and Development
- Harvard Medical School
- Uehara Memorial Foundation
- Japan Society for the Promotion of Science
- Japan Science and Technology Agency
Zitieren
APA
Nagai, J., Hastings, M. M., Nishida, A., Majumdar, S., Zaleski, K., Marshall, S. A., Lin, J., Saliman, M. A. S., Tani, Y., Murakami, Y., Feng, C., Perniss, A., Wong, C., Bankova, L. G., Inoue, A., Barrett, N. A., & Boyce, J. A. (2026). Mast cell-specific CysLT2 receptor signaling inhibits cysteinyl leukotriene-dependent mast cell activation and type 2 allergic lung inflammation. Cell Reports, 45(1), 116758. https://doi.org/10.1016/j.celrep.2025.116758
Vancouver
Nagai J, Hastings MM, Nishida A, Majumdar S, Zaleski K, Marshall SA, et al. Mast cell-specific CysLT2 receptor signaling inhibits cysteinyl leukotriene-dependent mast cell activation and type 2 allergic lung inflammation. Cell Reports. 2026;45(1):116758. doi:10.1016/j.celrep.2025.116758
BibTeX
@article{Nagai2026,
author = {Nagai, Jun and Hastings, Madeline M and Nishida, Airi and Majumdar, Sreyashi and Zaleski, Kendall and Marshall, Sofia A and Lin, Junrui and Saliman, Mira A S and Tani, Yumi and Murakami, Yamato and Feng, Chunli and Perniss, Alexander and Wong, Caitlin and Bankova, Lora G and Inoue, Asuka and Barrett, Nora A and Boyce, Joshua A},
title = {Mast cell-specific CysLT2 receptor signaling inhibits cysteinyl leukotriene-dependent mast cell activation and type 2 allergic lung inflammation},
journal = {Cell Reports},
year = {2026},
volume = {45},
number = {1},
pages = {116758},
doi = {10.1016/j.celrep.2025.116758}
}
EUVIMED